Virbac S.A.
VIRP.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.21B
Close$
$358.72
13.2% upside
Current Fair Value
13.2% upsideUndervalued by 13.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.21 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $1.45 (0.46%) |
| Earnings per Share | $17.98 |
| Beta | 0.79 |
| Outstanding Shares | 8,378,475 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 17.1 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 17, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$768.00 M
Average shareholder expectationNext Earnings Call
Expected Date
March 23, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$775.81 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Virbac S.A.
6,442 employees
CEO: Paul Martingell Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North ...